TUESDAY, Jan. 29, 2019 (HealthDay News) — Millions of hepatitis C cases and related deaths could be prevented, but it will require a significant investment, researchers say. In the first study to model such measures worldwide, the authors concluded that sweeping prevention, screening and treatment efforts could prevent 15.1 millionContinue Reading

WEDNESDAY, Jan. 23, 2019 (HealthDay News) — The percentage of U.S. liver transplant recipients with alcohol-associated liver disease (ALD) doubled over 15 years, but significant regional variations remain, a new study finds. ALD has replaced hepatitis C as the most common reason for U.S. liver transplants. One reason is thatContinue Reading

WEDNESDAY, Jan. 16, 2019 (HealthDay News) — The most common genetic disorder among northern Europeans — called hemochromatosis — occurs more often than previously thought, according to a new study. The researchers also found that people with the condition often develop serious health problems. People with hemochromatosis — a build-upContinue Reading

TUESDAY, Nov. 27, 2018 (HealthDay News) — A freeze-dried polio vaccine that could be used in locations without refrigeration might help doctors conquer the disease, researchers report. For the study, scientists freeze-dried the injectable vaccine into a powder and kept it at room temperature for four weeks. They then rehydratedContinue Reading

(HealthDay News) — An autoimmune disorder occurs when the immune system attacks the body itself, rather than disease-causing germs such as bacteria and viruses. The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases says symptoms of an autoimmune disorder typically include: Joint pain and stiffness. Thyroid problems, whichContinue Reading

TUESDAY, Oct. 2, 2018 (HealthDay News) — Only a small percentage of Americans have had their DNA analyzed — but many are tempted to try it, according to new research. For the study, University of Michigan researchers surveyed nearly 1,000 adults aged 50 to 64. While curious about their ancestryContinue Reading

TUESDAY, Sept. 18, 2018 (HealthDay News) — A new approach to preventing gout attacks looks promising for people not already helped by existing treatments. Researchers are looking at an anti-inflammatory drug called canakinumab (Ilaris) to treat this painful form of arthritis. Instead of targeting excessively high uric acid levels asContinue Reading